Close Menu

NEW YORK – Natera is selling its Evercord cord blood and tissue banking business to CBR (Cord Blood Registry), a California Cryobank Life Sciences company, the firms said today.

"This divestiture will allow Natera to focus squarely on its core genetic testing business in reproductive health, oncology, and organ transplantation," Natera CEO Steve Chapman said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.

Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.

Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.

In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.